← Back to all trials
Completed
NCT03860792
Therapeutic Diets in Alzheimer's Disease
Conditions: Alzheimer Disease
Sex: All
Ages: 50 Years – 90 Years
Healthy volunteers: No
Phase: NA
Enrollment: 84
Sponsor: University of Kansas Medical Center
Location: Clinical and Translational Science Unit Fairway Kansas
Summary
By doing this study, researchers hope to learn how the ketogenic and Therapeutic Lifestyles Changes diets affect cognition in patients with Alzheimer's disease.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of AD by current McKhann et al. criteria
* CDR global score of 0.5 or 1
* Agreed cooperation from an appropriate study partner
* Speaks English as primary language
* Age 50 to 90
* No medication changes within the past 30 days
Exclusion Criteria:
* Resides in a nursing home or dementia special care unit, or cannot control diet
* A potentially confounding serious medical risk including insulin-requiring diabetes, cancer requiring chemotherapy or radiation within the past 5 years, or a recent cardiac event (i.e. heart attack, angioplasty, etc.)
* Participating in another clinical trial or using an investigational drug or therapy within 30 days of the Screening Visit
* A history of renal stones
Source: ClinicalTrials.gov (NCT03860792). StuddyBuddy aggregates publicly available trial information.